Voyager Therapeutics
VYGR
116 hedge funds and large institutions have $117M invested in Voyager Therapeutics in 2025 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 34 increasing their positions, 42 reducing their positions, and 27 closing their positions.
33% more call options, than puts
Call options by funds: $169K | Put options by funds: $127K
0.44% less ownership
Funds ownership: 63.35% → 62.91% (-0.44%)
12% less funds holding
Funds holding: 132 → 116 (-16)
19% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 42
40% less capital invested
Capital invested by funds: $196M → $117M (-$78.7M)
56% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 27
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$3.09M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.49M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$966K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$732K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$540K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Prudential Financial
Newark,
New Jersey
|
-$1.87M |
| 2 |
GC
Globeflex Capital
San Diego,
California
|
-$1.65M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.12M |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$936K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$700K |
VYGR Hedge Fund Activity: Q1 2025 in Review
116 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q1 2025, worth a combined $117M — down 40% from $196M a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of VYGR and 12 opened new positions — a net loss of 15 holders — while 42 trimmed existing stakes and 34 added.
The largest buyer was Bank of America, adding an estimated $3.09M. The largest seller was Prudential Financial, exiting entirely with an estimated $1.87M sold.
- 116 institutional investors held Voyager Therapeutics (VYGR) as of Q1 2025, down from 132 in Q4 2024.
- Funds reported $117M of Voyager Therapeutics stock for Q1 2025, down 40% quarter-over-quarter.
- 12 funds opened new Voyager Therapeutics positions in Q1 2025 and 27 closed out, a net change of -15 holders.
- The largest Voyager Therapeutics buyer in Q1 2025 was Bank of America, an estimated $3.09M added.
- The largest Voyager Therapeutics seller in Q1 2025 was Prudential Financial, an estimated $1.87M sold.
Based on aggregated 13F filings for Q1 2025.